Zusammenfassung
Bei der juvenilen myelomonozytären Leukämie (JMML) handelt es sich um eine myeloproliferative Erkrankung der frühen Kindheit. Bei vielen Patienten lassen sich zugrunde liegende somatische, aber auch konstitutionelle Mutationen in NRAS, KRAS, PTPN11, NF1 und CBL nachweisen. Zur Identifizierung submikroskopischer Veränderungen, die für die leukämische Transformation von Bedeutung sein können, wurden 20 JMML-Proben mittels hochauflösender Oligo-Microarray-basierter komparativer genomischer Hybridisierung (aCGH) untersucht. Bei 2 von 10 Patienten mit submikroskopischen Aberrationen konnte ein nahezu identischer Zugewinn von Chromosom 8 gezeigt werden, der sich in weiteren Untersuchungen als konstitutionelles Mosaik darstellte. Eine Übersicht von 27 Patienten mit einem konstitutionellen Trisomie-8-Mosaik (cT8M) und maligner Neoplasie zeigte, dass es sich meist um myeloische Neoplasien, auch JMML, handelt. Durch unsere Untersuchungen konnte die kritische Region auf Chromosom 8, deren Loci mutmaßlich an der Leukämieentstehung und/oder Progression beteiligt sein können, dramatisch reduziert werden: 8p11.21q11.21. Es bleibt zu klären in welcher Form das partielle Trisomie-8-Mosaik an der Leukämieentstehung beteiligt ist und in welcher Weise dies für verschiedenen Mutationssubtypen der JMML eine Rolle spielt.
Abstract
Juvenile myelomonocytic leukemia (JMML) is a unique myeloproliferative disorder of early childhood in which mutations in NRAS, KRAS, PTPN11, NF1 and CBL are frequently found. Using high-resolution oligo array-based comparative genomic hybridization (aCGH), 20 JMML samples were investigated for submicroscopic genomic copy number alterations. Besides known cytogenetic aberrations, ten samples displayed additional submicroscopic alterations. Interestingly, an almost identical gain of chromosome 8 was identified in two patients. Subsequently, fluorescence in situ hybridization indicated a constitutional partial trisomy 8 mosaic (cT8M) in both patients. A survey on 27 cT8M patients with reported malignancies showed a predominance of myeloid malignancies including JMML. Our results dramatically reduce the critical region on chromosome 8 to 8p11.21q11.21. To determine how constitutional partial trisomy 8 mosaicisms may contribute to leukemogenesis in different mutational subtypes of JMML and other myeloid malignancies, further investigations are required.
Literatur
Akasaka T, Balasas T, Russell LJ et al (2007) Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109:3451–3461
Ando S, Maemori M, Sakai H et al (2005) Constitutional trisomy 8 mosaicism with myelodysplastic syndrome complicated by intestinal Behcet disease and antithrombin III deficiency. Cancer Genet Cytogenet 162:172–175
Basseres DS, Baldwin AS (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25:6817–6830
Bernasconi P, Orlandi E, Cavigliano P et al (2000) Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin’s lymphoma. Haematologica 85:1087–1091
Borrow J, Stanton VP Jr, Andresen JM et al (1996) The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 14:33–41
Brady AF, Waters CS, Pocha MJ, Brueton LA (2000) Chronic myelomonocytic leukaemia in a child with constitutional partial trisomy 8 mosaicism. Clin Genet 58:142–146
Bullinger L, Dohner K, Bair E et al (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350:1605–1616
Cappellini A, Tabellini G, Zweyer M et al (2003) The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. Leukemia 17:2157–2167
Champagne N, Pelletier N, Yang XJ (2001) The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene 20:404–409
Chen ZJ, Fuchs SY (2004) Ubiquitin-dependent activation of NF-kappaB: K63-linked ubiquitin chains: a link to cancer? Cancer Biol Ther 3:286–288
Cornaglia-Ferraris P, Ghio R, Barabino A et al (1981) Diminished in vitro colony forming capacity of bone marrow cells in a case of chromosome 8 trisomy (mosaicism): criteria for „high risk“ pre-leukemia syndrome. Boll Ist Sieroter Milan 60:69–73
Fine LA, Hoffman LD, Hoffman MD (2007) Aphthous ulcerations associated with trisomy 8-positive myelodysplastic syndrome. J Am Acad Dermatol 57:38–41
Flotho C, Valcamonica S, Mach-Pascual S et al (1999) RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 13:32–37
Gafter U, Shabtal F, Kahn Y et al (1976) Aplastic anemia followed by leukemia in congenital trisomy 8 mosaicism. Ultrastructural studies of polymorphonuclear cells in peripheral blood. Clin Genet 9:134–142
Ganmore I, Smooha G, Izraeli S (2009) Constitutional aneuploidy and cancer predisposition. Hum Mol Genet 18:R84–R93
Guzman ML, Neering SJ, Upchurch D et al (2001) Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 98:2301–2307
Haferlach T, Kohlmann A, Klein HU et al (2009) AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia 23:934–943
Hasle H, Clausen N, Pedersen B, Bendix-Hansen K (1995) Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype. Cancer Genet Cytogenet 79:79–81
Horwitz M (1997) The genetics of familial leukemia. Leukemia 11:1347–1359
Iwai K, Tokunaga F (2009) Linear polyubiquitination: a new regulator of NF-kappaB activation. EMBO Rep 10:706–713
Kapaun P, Kabisch H, Held KR et al (1993) Atypical chronic myelogenous leukemia in a patient with trisomy 8 mosaicism syndrome. Ann Hematol 66:57–58
Karadima G, Bugge M, Nicolaidis P et al (1998) Origin of nondisjunction in trisomy 8 and trisomy 8 mosaicism. Eur J Hum Genet 6:432–438
Knuutila S, Teerenhovi L, Larramendy ML et al (1994) Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms. Genes Chromosomes Cancer 10:95–102
Kratz CP, Niemeyer CM, Castleberry RP et al (2005) The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood 106:2183–2185
Lauchle JO, Braun BS, Loh ML, Shannon K (2006) Inherited predispositions and hyperactive Ras in myeloid leukemogenesis. Pediatr Blood Cancer 46:579–585
Lessick M, Israel J, Szego K, Wong P (1990) Leiomyosarcoma in a patient with trisomy 8 mosaicism. J Med Genet 27:643–644
Loh ML, Sakai DS, Flotho C et al (2009) Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood 114:1859–1863
Mark FL, Ahearn J, Lathrop JC (1995) Constitutional trisomy 8 mosaicism and gestational trophoblastic disease. Cancer Genet Cytogenet 80:150–154
Marti S, Galan FM, Casero JM et al (2008) Characterization of trisomic natural killer cell abnormalities in a patient with constitutional trisomy 8 mosaicism. Pediatr Blood Cancer 25:135–146
Maserati E, Aprili F, Vinante F et al (2002) Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15–20% of cases. Genes Chromosomes Cancer 33:93–97
Maserati E, Pressato B, Valli R et al (2007) Constitutional trisomy 8 mosaicism in primary myelofibrosis: relevance to clinical practice and warning for trisomy 8 studies. Cancer Genet Cytogenet 179:79–81
Mastrangelo R, Tornesello A, Mastrangelo S et al (1995) Constitutional trisomy 8 mosaicism evolving to primary myelodysplastic syndrome: a new subset of biologically related patients? Am J Hematol 48:67–68
Nakamura Y, Nakashima H, Fukuda S et al (1985) Bilateral cystic nephroblastomas and multiple malformations with trisomy 8 mosaicism. Hum Pathol 16:754–756
Narendran A, Hawkins LM, Ganjavi H et al (2004) Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome. Pediatr Hematol Oncol 21:209–221
Nielsen J, Wohlert M (1991) Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87:81–83
Niemeyer CM, Arico M, Basso G et al (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89:3534–3543
Niemeyer CM, Kang MW, Shin DH et al (2010) Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet 42:794–800
Niss R, Passarge E (1976) Trisomy 8 restricted to cultured fibroblasts. J Med Genet 13:229–234
Nylund SJ, Verbeek W, Larramendy ML et al (1993) Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization. Cancer Genet Cytogenet 70:120–124
Palmer CG, Provisor AJ, Weaver DD et al (1983) Juvenile chronic granulocytic leukemia in a patient with trisomy 8, neurofibromatosis, and prolonged Epstein-Barr virus infection. J Pediatr 102:888–892
Paulsson K, Johansson B (2007) Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes. Pathol Biol (Paris) 55:37–48
Paulsson K, Panagopoulos I, Knuutila S et al (2003) Formation of trisomies and their parental origin in hyperdiploid childhood acute lymphoblastic leukemia. Blood 102:3010–3015
Riccardi VM, Humbert JR, Peakman D (1978) Acute leukemia associated with trisomy 8 mosaicism and a familial translocation 46, XY, t(7;20)(p13;p12). Am J Med Genet 2:15–21
Ripperger T, Tauscher M, Praulich I et al (2011) Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia. Br J Haematol 155:209–217
Schaich M, Schlenk RF, Al Ali HK et al (2007) Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Haematologica 92:763–770
Seghezzi L, Maserati E, Minelli A et al (1996) Constitutional trisomy 8 as first mutation in multistep carcinogenesis: clinical, cytogenetic, and molecular data on three cases. Genes Chromosomes Cancer 17:94–101
Steinemann D, Arning L, Praulich I et al (2010) Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Haematologica 95:320–323
Stiller CA, Chessells JM, Fitchett M (1994) Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 70:969–972
Storlazzi CT, Fioretos T, Paulsson K et al (2004) Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies. Hum Mol Genet 13:1479–1485
Sun T, Wu E (2001) Acute monoblastic leukemia with t(8;16): a distinct clinicopathologic entity; report of a case and review of the literature. Am J Hematol 66:207–212
Swarthout JT, Lobo S, Farh L et al (2005) DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras. J Biol Chem 280:31141–31148
Tartaglia M, Gelb BD (2005) Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet 6:45–68
Tartaglia M, Niemeyer CM, Fragale A et al (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148–150
Virtaneva K, Wright FA, Tanner SM et al (2001) Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A 98:1124–1129
Wang T, Danielson PD, Li BY et al (1996) The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling. Science 271:1120–1122
Welborn J (2004) Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies. Cancer Genet Cytogenet 149:137–153
Wu X, Yamamoto M, Akira S, Sun SC (2009) Regulation of hematopoiesis by the K63-specific ubiquitin-conjugating enzyme Ubc13. Proc Natl Acad Sci U S A 106:20836–20841
Yamamoto K, Okamura A, Kawano H et al (2007) A novel t(8;18)(q13;q21) in acute monocytic leukemia evolving from constitutional trisomy 8 mosaicism. Cancer Genet Cytogenet 176:144–149
Zollino M, Genuardi M, Bajer J et al (1995) Constitutional trisomy 8 and myelodysplasia: report of a case and review of the literature. Leuk Res 19:733–736
Danksagung
Wir danken allen an der Studie beteiligten Patienten und Kollegen. Die Arbeit von Tim Ripperger wurde zum Teil durch ein Stipendium der Hannover Biomedical Research School, PhD Programm Molecular Medicine finanziert. Abschließend danken wir Gillian Teicke für die kritische Durchsicht des Manuskriptes und dem British Journal of Haematology (Wiley-Blackwell), dass wir die Abbildung aus der Originalpublikation des Artikels [44] weitestgehend identisch verwenden konnten.
Interessenkonflikt
Die korrespondierende Autorin gibt für sich und ihre Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ripperger, T., Schlegelberger, B. & Steinemann, D. Mosaiktrisomie 8p11.21q11.21 als Prädisposition für myeloische Leukämien. medgen 24, 33–39 (2012). https://doi.org/10.1007/s11825-012-0316-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11825-012-0316-1
Schlüsselwörter
- Juvenile myelomonozytäre Leukämie
- Arraybasierte komparative genomische Hybridisierung
- Trisomie 8
- Leukämieprädisposition